Traditional Chinese medicine prescription for treating ovarian insufficiency

Abstract

The invention discloses a traditional Chinese medicine prescription for treating ovarian insufficiency. The prescription is prepared from ,by weight,6-12 parts of radix bupleuri,5-15 parts of angelicasinensis,3-9 parts of rhizoma chuanxiong,5-15 parts of radix paeoniae alba,5-15 parts of prepared rhizome of rehmannia,5-15 parts of radix codcnopsitis pilosulas,6-12 parts of rhizoma atractylodis macrocephalae,5-15 parts of poria,5-15 parts of deer-horn glue,5-15 parts of radix cyathulae,5-15 parts of rhizoma cyperi and 3-6 parts of dried orange peel. The traditional Chinese medicine prescription has ingenious and refined compatibility, and clinical application proves that the traditional Chinese medicine prescription can effectively improve the ovarian sex hormone level, recover the ovarianfunction to a certain extent, improve the natural pregnancy rate of a patient, and improve the hectic fever sweating, palpitation, dysphoria, insomnia and other perimenopause syndromes of a POI patient; the prescription has wide clinic promotion prospects, is prepared into various dosage forms of Chinese patent medicine and is more convenient for patients; the total cost is low, so that the economic burden of such patients can be greatly reduced, and the medical burden of the country can be reduced to a certain extent.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine and specifically refers to a traditional Chinese medicine prescription for treating ovarian insufficiency (POI). Background technique [0002] Premature ovary insufficiency (POI) refers to women who have established regular menstruation, before the age of 40, persistent amenorrhea and reproductive organ atrophy due to ovarian function decline, often accompanied by increased gonadotropin levels and decreased estrogen , the clinical manifestations are amenorrhea, infertility, varying degrees of hot flashes, hyperhidrosis, vaginal dryness, mood swings, dizziness, insomnia, and decreased libido, which are similar to menopausal symptoms of low ovarian function. The incidence rate is 1-2%, and the cause of the disease has not been fully clarified. 90% of the cases are idiopathic, and 10% are related to autoimmunity, infection, gene and iatrogenic. POI has great long-term harm, and ...

AI Technical Summary

Problems solved by technology

Family history of breast cancer or breast hyperplasia, uterine fibroids, etc. are contraindications for HRT. Because of the above-mentioned side effects, some scholars have suggested that HRT is only suitable for POI patients over 51 years old (close to the normal menopausal age)